Last quarter (Q ), GeneThera's total revenue was $―, a decrease of ― from the same quarter last year. In Q, GeneThera's net income was $-125.57K. See GeneThera’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Total Revenue	-	-	-	$ 0.00	$ 0.00	$ 0.00
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expense	$ 682.86K	$ 1.01M	$ 774.46K	$ 739.15K	$ 3.93M	$ 605.70K
Operating Income	$ -682.86K	$ -1.01M	$ -774.46K	$ -739.15K	$ -3.93M	$ -605.70K
Net Non Operating Interest Income Expense	$ -3.34K	$ -2.22K	$ -33.85K	$ -28.58K	$ -117.97K	$ -146.62K
Other Income Expense	-	-	-	$ 250.08K	$ 648.35K	$ -5.40K
Pretax Income	$ -681.26K	$ -1.01M	$ -808.32K	$ -517.65K	$ -3.40M	$ -757.72K
Tax Provision	-	-	-	$ 0.00	$ 0.00	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -681.26K	$ -1.01M	$ -808.32K	$ -517.65K	$ -3.40M	$ -757.72K
Basic EPS	$ -0.01	$ -0.04	$ -0.04	$ -0.01	$ -0.09	$ -0.02
Diluted EPS	$ -0.01	$ -0.04	$ -0.04	$ -0.01	$ -0.09	$ -0.02
Basic Average Shares	$ 59.44M	$ 25.35M	$ 20.31M	$ 35.90M	$ 38.20M	$ 40.06M
Diluted Average Shares	$ 59.44M	$ 25.35M	$ 20.31M	$ 35.90M	$ 38.20M	$ 40.06M
Dividend Per Share	-	-	-	$ 0.00	$ 0.00	$ 0.00
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 682.86K	$ 1.01M	$ 774.46K	$ 739.15K	$ 3.93M	$ 605.70K
Net Income From Continuing And Discontinued Operation	$ -681.26K	$ -1.01M	$ -808.32K	$ -517.65K	$ -3.40M	$ -757.72K
Normalized Income	$ -407.75K	-	-	$ -767.73K	$ -4.04M	$ -752.32K
Interest Expense	$ 2.78K	-	-	$ 28.58K	$ 117.97K	$ 146.62K
EBIT	$ -677.93K	$ -1.01M	$ -774.46K	$ -489.07K	$ -3.28M	$ -611.10K
EBITDA	$ -672.65K	$ -1.00M	$ -769.18K	$ -483.79K	$ -3.27M	$ -611.10K

Currency in USD

GeneThera Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing